Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2023 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.01 per share
Symbol
ELTX on Nasdaq
Shares outstanding
16,785,250
Price per share
$7.96
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
1,911,273
Total reported value
$20,875,759
% of total 13F portfolios
0%
Share change
+460,539
Value change
+$5,121,932
Number of holders
28
Price from insider filings
$7.96
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GKCC, LLC 48% $115,225,395 9,764,864 Yekaterina Chudnovsky 03 Jun 2025
Chudnovsky Yekaterina 48% $59,490,440 9,657,539 Yekaterina Chudnovsky 05 Mar 2025
Knoll Capital Management, LLC 5.2% $3,886,436 630,915 Knoll Capital Management, LLC 30 Jan 2025
Actyus Private Equity SGIIC, S.A. 1.6% -76% $3,142,199 -$6,877,471 268,564 -69% Actyus Private Equity SGIIC, S.A. 30 Sep 2025

As of 30 Sep 2025, 28 institutional investors reported holding 1,911,273 shares of Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX). This represents 11% of the company’s total 16,785,250 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX) together control 11% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Knoll Capital Management, LLC 3.8% 630,915 0% 3.7% $6,902,210
VANGUARD GROUP INC 2.8% 473,859 +4.2% 0% $5,184,017
Balyasny Asset Management L.P. 0.88% 148,076 0% $1,619,951
GEODE CAPITAL MANAGEMENT, LLC 0.77% 129,686 +7.3% 0% $1,419,343
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.72% 120,207 +606% 0% $1,315,065
MARSHALL WACE, LLP 0.52% 86,533 0% $946,672
NORTHERN TRUST CORP 0.32% 53,584 +5.1% 0% $586,209
RENAISSANCE TECHNOLOGIES LLC 0.29% 48,671 0% $532,461
BlackRock, Inc. 0.26% 44,195 +1.5% 0% $483,493
STATE STREET CORP 0.23% 38,300 +77% 0% $419,002
Cresset Asset Management, LLC 0.16% 26,925 0% $294,560
MILLENNIUM MANAGEMENT LLC 0.14% 22,846 0% $249,935
MEYER HANDELMAN CO 0.08% 13,899 0% 0% $152,055
CITIGROUP INC 0.06% 10,658 0% $116,599
Mayflower Financial Advisors, LLC 0.06% 10,000 0% 0.01% $109,400
&PARTNERS 0.06% 10,000 0% 0% $109,400
MOODY LYNN & LIEBERSON, LLC 0.06% 10,000 0% 0.01% $109,400
UBS Group AG 0.04% 7,019 +17% 0% $76,787
CIBC Private Wealth Group LLC 0.04% 7,000 0% 0% $42,560
CM Management, LLC 0.04% 6,000 -76% 0.05% $65,640
Jefferies Financial Group Inc. 0.03% 5,200 0% $56,888
BANK OF AMERICA CORP /DE/ 0.02% 3,585 +187% 0% $39,220
Steward Partners Investment Advisory, LLC 0.01% 1,554 0% 0% $17,001
MORGAN STANLEY 0.01% 1,536 +304% 0% $16,804
Farther Finance Advisors, LLC 0% 640 0% $7,002

Institutional Holders of Elicio Therapeutics, Inc. - Common Stock, par value $0.01 per share (ELTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 10,000 $79,600 $7.96 1
2025 Q3 1,911,273 $20,875,759 +$5,121,932 $10.94 28
2025 Q2 1,450,816 $11,188,879 -$640,776 $7.72 21
2025 Q1 1,591,744 $9,804,572 +$7,009,112 $6.16 24
2024 Q4 454,072 $2,254,908 -$189,626 $5.10 17
2024 Q3 491,473 $2,479,497 -$395,066 $5.03 18
2024 Q2 648,667 $2,679,243 +$950,467 $4.11 19
2024 Q1 405,679 $3,072,195 +$531,386 $7.60 16
2023 Q4 332,813 $2,775,559 +$9,459 $8.34 17
2023 Q3 330,928 $2,796,450 +$381,645 $8.45 17
2023 Q2 285,765 $2,714,943 +$2,714,945 $9.50 15